Skip to main content

Table 3 Availability of malaria commodities and readiness for case management in the public sector, among all screened outlets

From: Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies

 

Public health facility

Community health workers

All public sector

N = 173

N = 430

N = 603

% (95% CI)

% (95% CI)

% (95% CI)

Diagnostics

 Any malaria blood testing

82.3 (74.9, 87.8)

87.2 (82.7, 90.6)

85.9 (82.1, 89.0)

 Malaria microscopy

27.8 (21.0, 35.8)

0.3 (0.1, 1.8)

7.2 (5.3, 9.7)

 RDT

81.7 (74.3, 87.4)

87.2 (82.7, 90.6)

85.8 (81.9, 88.9)

Anti-malarials

 Any first-line ACT (DHA PPQ and/or ASMQ FDC)

76.5 (67.8, 83.5)

74.1 (66.2, 80.7)

74.7 (68.3, 80.1)

 DHA PPQ

76.5 (67.8, 83.5)

74.1 (66.2, 80.7)

74.7 (68.3, 80.1)

 ASMQ FDC

0.0 (–)

0.0 (–)

0.0 (–)

 Primaquine

0.0 (–)

0.0 (–)

0.0 (–)

 Other non-artemisinin therapy

8.9 (4.9, 15.5)

0.0 (–)

2.2 (1.3, 3.9)

 IV/IM artesunate

0.0 (–)

n/a

0.0 (–)

Readiness

 Availability of first-line ACT and malaria blood testing

75.9 (67.1, 82.9)

67.7 (60.2, 74.3)

69.7 (63.6, 75.1)

 Availability of first-line ACT, blood testing not available

0.7 (0.2, 2.4)

6.4 (4.1, 9.9)

5.0 (3.2, 7.6)